Matches in Wikidata for { <http://www.wikidata.org/entity/Q91875412> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- Q91875412 description "article scientifique publié en 2018" @default.
- Q91875412 description "artículu científicu espublizáu en xunetu de 2018" @default.
- Q91875412 description "im Juli 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91875412 description "scientific article published on 16 July 2018" @default.
- Q91875412 description "wetenschappelijk artikel" @default.
- Q91875412 description "наукова стаття, опублікована в липні 2018" @default.
- Q91875412 name "Efficacy and safety of ipragliflozin as add-on therapy to insulin in Japanese patients with type 2 diabetes mellitus (IOLITE): a 36-week, open-label extension of a 16-week, randomized, placebo-controlled, double-blind study" @default.
- Q91875412 name "Efficacy and safety of ipragliflozin as add-on therapy to insulin in Japanese patients with type 2 diabetes mellitus (IOLITE): a 36-week, open-label extension of a 16-week, randomized, placebo-controlled, double-blind study" @default.
- Q91875412 type Item @default.
- Q91875412 label "Efficacy and safety of ipragliflozin as add-on therapy to insulin in Japanese patients with type 2 diabetes mellitus (IOLITE): a 36-week, open-label extension of a 16-week, randomized, placebo-controlled, double-blind study" @default.
- Q91875412 label "Efficacy and safety of ipragliflozin as add-on therapy to insulin in Japanese patients with type 2 diabetes mellitus (IOLITE): a 36-week, open-label extension of a 16-week, randomized, placebo-controlled, double-blind study" @default.
- Q91875412 prefLabel "Efficacy and safety of ipragliflozin as add-on therapy to insulin in Japanese patients with type 2 diabetes mellitus (IOLITE): a 36-week, open-label extension of a 16-week, randomized, placebo-controlled, double-blind study" @default.
- Q91875412 prefLabel "Efficacy and safety of ipragliflozin as add-on therapy to insulin in Japanese patients with type 2 diabetes mellitus (IOLITE): a 36-week, open-label extension of a 16-week, randomized, placebo-controlled, double-blind study" @default.
- Q91875412 P1433 Q91875412-B3C8D1D9-27CF-4ED9-8802-86316B91F10D @default.
- Q91875412 P1476 Q91875412-074DFAB3-DDEB-41A3-A1C0-6D05D016A5CE @default.
- Q91875412 P2093 Q91875412-1397E337-C82C-4C4A-9A09-ABB0B9B85D43 @default.
- Q91875412 P2093 Q91875412-4B34C5BF-BE91-4E35-8346-CC74AB3992EE @default.
- Q91875412 P2093 Q91875412-613AD36A-6946-4A56-A474-60EA2DA32061 @default.
- Q91875412 P2093 Q91875412-CAC695EA-DEF3-473A-8095-C2AC82D38C08 @default.
- Q91875412 P2093 Q91875412-F47EF5DB-3CF5-4B80-95C4-E7AFE8A74AB2 @default.
- Q91875412 P2860 Q91875412-1F9096CD-55D4-41C5-B42A-33E1C9C54775 @default.
- Q91875412 P2860 Q91875412-243041FF-5D13-4132-AF48-EFAC8F7C4CA2 @default.
- Q91875412 P2860 Q91875412-393A91F6-1CE4-4249-8DA2-2AA5AA3FCB93 @default.
- Q91875412 P2860 Q91875412-3D16382D-4D6B-4636-AE83-C36F474B0714 @default.
- Q91875412 P2860 Q91875412-48F28776-336E-40F9-9589-6334DE039819 @default.
- Q91875412 P2860 Q91875412-64D638FC-9E36-44E6-9183-A5F5C3E48009 @default.
- Q91875412 P2860 Q91875412-697A7839-FA34-4FF2-A519-F3FD80DF05A8 @default.
- Q91875412 P2860 Q91875412-70F2BDC7-4B17-4B7C-9A1F-2ADAA8B8BC25 @default.
- Q91875412 P2860 Q91875412-84FACCB6-814E-4F38-BD78-64886A2085B5 @default.
- Q91875412 P2860 Q91875412-9239A8B3-6DB6-4DA1-B80B-BAF1CD255841 @default.
- Q91875412 P2860 Q91875412-B5595A6D-0419-4A1E-807B-CFFADE78B2A1 @default.
- Q91875412 P2860 Q91875412-B9895DD8-704F-4664-8857-858FFAD626EB @default.
- Q91875412 P2860 Q91875412-BCE3DD7E-2807-48D9-94B9-9AACFB3944C1 @default.
- Q91875412 P2860 Q91875412-BF579176-E653-458A-94A7-9D79F158341C @default.
- Q91875412 P2860 Q91875412-CEA7BB68-A9C7-459A-9378-05011CB5D448 @default.
- Q91875412 P2860 Q91875412-F7890E2F-AFD3-460A-AA96-95BD75B00644 @default.
- Q91875412 P2860 Q91875412-F9451A2B-E728-43AD-8679-E6763B950807 @default.
- Q91875412 P304 Q91875412-90538417-64E7-41DA-A635-AB92AD2F380A @default.
- Q91875412 P31 Q91875412-E67DB454-F99B-4D54-993D-C064A9DF635F @default.
- Q91875412 P356 Q91875412-7B3EDE53-1C09-4EB8-9E0E-BE24875FB362 @default.
- Q91875412 P433 Q91875412-9A6517D9-1553-487F-A3B1-78D745592DCB @default.
- Q91875412 P478 Q91875412-95DE1044-7189-4E96-943B-4F68F3874D0C @default.
- Q91875412 P577 Q91875412-0A50AB10-B45E-4030-BBBB-AB8FD2D78F69 @default.
- Q91875412 P698 Q91875412-234389E6-A854-4057-8F45-F56CD35C7E51 @default.
- Q91875412 P921 Q91875412-A4786B3C-981F-4D09-9280-F41DBE894239 @default.
- Q91875412 P921 Q91875412-C8C50D76-0BB2-4EFD-8866-7E1F9B2BB176 @default.
- Q91875412 P932 Q91875412-4E5CA2D3-235D-4ECA-A295-B0A36AF7501B @default.
- Q91875412 P356 S13340-018-0359-X @default.
- Q91875412 P698 30800562 @default.
- Q91875412 P1433 Q27727408 @default.
- Q91875412 P1476 "Efficacy and safety of ipragliflozin as add-on therapy to insulin in Japanese patients with type 2 diabetes mellitus (IOLITE): a 36-week, open-label extension of a 16-week, randomized, placebo-controlled, double-blind study" @default.
- Q91875412 P2093 "Hisamitsu Ishihara" @default.
- Q91875412 P2093 "Ikko Nakao" @default.
- Q91875412 P2093 "Seitaro Asahina" @default.
- Q91875412 P2093 "Susumu Yamaguchi" @default.
- Q91875412 P2093 "Taishi Sakatani" @default.
- Q91875412 P2860 Q34407893 @default.
- Q91875412 P2860 Q35772077 @default.
- Q91875412 P2860 Q36073434 @default.
- Q91875412 P2860 Q37018165 @default.
- Q91875412 P2860 Q37060860 @default.
- Q91875412 P2860 Q37257445 @default.
- Q91875412 P2860 Q37279276 @default.
- Q91875412 P2860 Q37366361 @default.
- Q91875412 P2860 Q37937592 @default.
- Q91875412 P2860 Q38299208 @default.
- Q91875412 P2860 Q38618376 @default.
- Q91875412 P2860 Q40405896 @default.
- Q91875412 P2860 Q40606871 @default.
- Q91875412 P2860 Q41168197 @default.
- Q91875412 P2860 Q41277849 @default.
- Q91875412 P2860 Q43165555 @default.
- Q91875412 P2860 Q47871792 @default.
- Q91875412 P304 "37-50" @default.
- Q91875412 P31 Q13442814 @default.
- Q91875412 P356 "10.1007/S13340-018-0359-X" @default.
- Q91875412 P433 "1" @default.
- Q91875412 P478 "10" @default.
- Q91875412 P577 "2018-07-16T00:00:00Z" @default.
- Q91875412 P698 "30800562" @default.
- Q91875412 P921 Q269829 @default.
- Q91875412 P921 Q3025883 @default.
- Q91875412 P932 "6357239" @default.